Analysis of Effect of Bisphosphonate for Radionuclide Uptake in Bone Scintigraphy during Cancer Treatment

 Fatima Arfan, N. Batool, N. Arshad, Warda Mehak, S. Abbas, Abid Ali
{"title":"Analysis of Effect of Bisphosphonate for Radionuclide Uptake in Bone Scintigraphy during Cancer Treatment","authors":" Fatima Arfan, N. Batool, N. Arshad, Warda Mehak, S. Abbas, Abid Ali","doi":"10.36349/easjrit.2021.v03i02.008","DOIUrl":null,"url":null,"abstract":"Quick Response Code Abstract: Introduction: Bone scan is most commonly performed scan in nuclear medicine. There exists a relationship between bone scan and bisphosphonate therapy because after bisphosphonate therapy bone scan is mandatory. Optical scintigraphy and magnetic resonance imaging are two emerging molecular imaging methods used to test bone physiology. This review focuses on nuclear bone scintigraphy since it is the most well-established method with a large body of research data to back it up in clinical practice. The radionuclides technetium-99m (Tc-99m) and fluoride-18 are commonly used in bone nuclear scintigraphy (F-18). Tc-99m and F-18 are generally correlated with Medtronic destructive (Tc-99m MDP) and fluoride and sodium, respectively (F-18 NaF). The decay of photons from the radioisotope is captured by a nuclear camera holding a salt valuable stone after these particles are inserted intravenously. This is accomplished by the shimmering or fluorescence technique, which occurs when a photon emitted by a radionuclide collides with a salt useful stone within a nuclear camera. Methodology: It was an Observational study of 30 patients conducted at Department of Nuclear Medicine, INMOL Lahore from November 2020-February 2021. Cancer patients of both male and female genders receiving bisphosphonate therapies were included in this study. The age and gender matched patients were included. Objective: The aim of the research was to see how bisphosphonates affected oncology patients' bone scans. The key goal of this research was to see how bisphosphonates therapy affected bone scan. Results and Conclusion: The overall uptake of radiopharmaceutical in bone tends to increase after bisphosphonates therapy. The relationship between the bisphosphonate therapy given to the patients and their bone scan is significant. The study hypothesis is accepted that bisphosphonate. Hence effect of bisphosphonate therapy on skeletal system can be monitored by bone scan.","PeriodicalId":429686,"journal":{"name":"EAS Journal of Radiology and Imaging Technology","volume":"17 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2021-04-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"EAS Journal of Radiology and Imaging Technology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.36349/easjrit.2021.v03i02.008","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Quick Response Code Abstract: Introduction: Bone scan is most commonly performed scan in nuclear medicine. There exists a relationship between bone scan and bisphosphonate therapy because after bisphosphonate therapy bone scan is mandatory. Optical scintigraphy and magnetic resonance imaging are two emerging molecular imaging methods used to test bone physiology. This review focuses on nuclear bone scintigraphy since it is the most well-established method with a large body of research data to back it up in clinical practice. The radionuclides technetium-99m (Tc-99m) and fluoride-18 are commonly used in bone nuclear scintigraphy (F-18). Tc-99m and F-18 are generally correlated with Medtronic destructive (Tc-99m MDP) and fluoride and sodium, respectively (F-18 NaF). The decay of photons from the radioisotope is captured by a nuclear camera holding a salt valuable stone after these particles are inserted intravenously. This is accomplished by the shimmering or fluorescence technique, which occurs when a photon emitted by a radionuclide collides with a salt useful stone within a nuclear camera. Methodology: It was an Observational study of 30 patients conducted at Department of Nuclear Medicine, INMOL Lahore from November 2020-February 2021. Cancer patients of both male and female genders receiving bisphosphonate therapies were included in this study. The age and gender matched patients were included. Objective: The aim of the research was to see how bisphosphonates affected oncology patients' bone scans. The key goal of this research was to see how bisphosphonates therapy affected bone scan. Results and Conclusion: The overall uptake of radiopharmaceutical in bone tends to increase after bisphosphonates therapy. The relationship between the bisphosphonate therapy given to the patients and their bone scan is significant. The study hypothesis is accepted that bisphosphonate. Hence effect of bisphosphonate therapy on skeletal system can be monitored by bone scan.
双膦酸盐对肿瘤治疗期间骨显像中放射性核素摄取的影响分析
摘要:骨扫描是核医学中最常用的扫描方式。骨扫描与双膦酸盐治疗之间存在关系,因为在双膦酸盐治疗后,骨扫描是强制性的。光学闪烁成像和磁共振成像是两种新兴的用于骨生理学测试的分子成像方法。本综述的重点是核骨闪烁成像,因为它是最完善的方法,有大量的研究数据来支持它在临床实践中。放射性核素锝-99m (Tc-99m)和氟化物-18通常用于骨核闪烁成像(F-18)。Tc-99m和F-18一般分别与美敦力破坏性(Tc-99m MDP)和氟化物和钠(F-18 NaF)相关。将放射性同位素的光子通过静脉注射注入体内后,由一个手持有盐价值的石头的核照相机捕捉到这些光子的衰变过程。这是通过闪烁或荧光技术实现的,当放射性核素发射的光子与核相机内的盐有用石碰撞时,就会发生这种情况。方法:这是一项观察性研究,涉及30名患者,于2020年11月至2021年2月在拉合尔INMOL核医学系进行。接受双膦酸盐治疗的男性和女性癌症患者均被纳入本研究。纳入年龄和性别匹配的患者。目的:研究的目的是了解双膦酸盐如何影响肿瘤患者的骨扫描。这项研究的主要目的是观察双膦酸盐治疗如何影响骨扫描。结果与结论:双膦酸盐治疗后,骨对放射性药物的总体吸收有增加的趋势。给予患者的双膦酸盐治疗与骨扫描之间的关系是显著的。研究假设被接受为双膦酸盐。因此,双膦酸盐治疗对骨骼系统的影响可以通过骨扫描监测。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信